HALO
Halozyme Therapeutics, Inc. (HALO)
Last Price$61.4(0.0%)
Market Cap$7,773.1M
Last Earnings date
Dec'24
Q4 2024
$1.08
6.8% miss
Next quarter EPS Estimate
$0.97
22.8%YoY

HALO Earnings and Expectations

Revenue

Crunching data... Almost there!

HALO EPS (Earnings Per Share)

Crunching data... Almost there!

HALO Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$50.0M$100.0M$150.0M$200.0M$250.0M$300.0MApr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24Oct'24$25.4M$65.3M$89.0M$115.8M$117.3M$209.0M$162.1M$216.0M$195.9M$290.1M
Value Sense
Actual Revenue
Forecast Revenue

HALO Earnings History

Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$18.7M$43.4M$20.8M$52.2M$42.5M$33.3M$31.9M$39.0M$29.6M$33.8M$63.7M$189.6M$30.9M$35.2M$25.6M$60.2M$56.9M$39.1M$46.2M$53.7M$25.4M$55.2M$65.3M$121.7M$89.0M$136.5M$115.8M$102.0M$117.3M$152.4M$209.0M$181.5M$162.1M$221.0M$216.0M$230.0M$195.9M$231.4M$290.1M$298.0M
Revenue estimate$20.3M$20.3M$20.3M$20.3M$53.1M$53.1M$53.1M$53.1M$28.5M$28.5M$28.5M$28.5M$35.8M$35.8M$35.8M$35.8M$67.8M$42.8M$55.0M$56.9M$43.0M$66.7M$59.9M$120.0M$84.9M$104.1M$105.8M$101.5M$128.3M$138.6M$191.2M$192.1M$179.3M$200.0M$216.1M$231.0M$199.7M$204.9M$252.2M$285.7M
Revenue surprise7.9%114.2%2.6%157.8%20.0%37.2%40.0%26.6%3.9%18.6%123.9%566.0%13.7%1.6%28.6%68.3%16.0%8.5%15.9%5.7%41.0%17.2%9.0%1.4%4.9%31.1%9.4%0.5%8.6%9.9%9.3%5.5%9.6%10.5%0.0%0.4%1.9%12.9%15.0%4.3%
EPS actual($0.12)$0.02($0.19)$0.03($0.16)($0.21)($0.23)($0.22)($0.26)($0.23)$0.02$0.87($0.19)($0.16)($0.19)($0.02)$0.01($0.10)($0.17)($0.24)($0.04)$0.19$0.27$0.54$0.20$0.64$1.53$0.48$0.44$0.16$0.45$0.43$0.29$0.57$0.62$0.66$0.61$0.73$1.08$1.08
EPS estimate($0.14)($0.14)($0.14)($0.14)($0.24)($0.24)($0.24)($0.24)($0.24)($0.24)($0.24)($0.24)($0.25)($0.25)($0.25)($0.25)$0.01($0.14)($0.12)($0.18)($0.02)$0.25$0.19$0.53$0.32$0.43$0.42$0.38$0.46$0.47$0.36$0.30$0.38$0.63$0.71$0.83$0.69$0.76$0.99$1.16
EPS surprise14.3%114.3%35.7%121.4%33.3%12.5%4.2%8.3%8.3%4.2%108.3%462.5%24.0%36.0%24.0%93.9%27.9%29.2%40.0%31.8%114.3%22.8%38.6%2.1%37.1%47.2%261.3%24.8%4.6%66.0%24.4%43.9%24.2%9.5%12.2%20.0%11.1%3.8%9.0%6.8%

Overview of financial statements

Income statement
Balance sheet
Cash Flow statement
$298.0M 29.5% YoY
$256.0M 44.0% YoY
85.9% margin
Cost of revenue
$42.1M (19.6%) YoY
Operating income
$175.5M 73.7% YoY
58.9% margin
Other: $7,253.0K
Net interest: $4,540.0K
Operating expenses
$80.5M 4.9% YoY
Pre-tax income
$178.2M 76.1% YoY
59.8% margin
Net income
$137.0M 60.5% YoY
46.0% margin
Income tax
$41.2M
23.1% tax rate
R&D
$20.4M (4.2%) YoY
6.9% of revenue
SG&A
$42.2M 12.3% YoY
14.2% of revenue

Competing with HALO Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$7,773.1M
$1,015.3M
$3.50
29.5%
63.6%
Beat by 18.2%
Beat by 9.0%
(23.1%)
(11.4%)
Beats: 7
Misses: 3
17.2%
44.6%
$124.8B
$11.0B
($2.06)
15.7%
(5.6%)
Beat by 8.4%
Miss by 12.9%
(1.7%)
20.2%
Beats:
Misses:
8.6%
(962.4%)
$77.0B
$14.2B
$40.88
10.3%
(21.6%)
Beat by 3.1%
Miss by 27.1%
(10.2%)
9.3%
Beats: 8
Misses: 2
2.4%
3.1%
$34.4B
$2,258.9M
($1.77)
73.8%
N/A
Beat by 40.1%
Miss by 281.3%
23.0%
13.8%
Beats: 7
Misses: 3
76.3%
(132.2%)
$30.7B
$2,248.2M
($2.17)
34.9%
(40.9%)
Beat by 11.3%
Miss by 29.1%
(0.4%)
45.9%
Beats: 8
Misses: 2
28.6%
(26.5%)
$24.0B
€2,751.1M
(€3.84)
(19.5%)
(100.0%)
Beat by 5.2%
Miss by 100.0%
(79.9%)
0.0%
Beats: 5
Misses: 5
(28.0%)
(182.9%)
$14.5B
$2,263.9M
$2.31
(0.3%)
(58.6%)
Miss by 14.8%
Miss by 50.4%
22.5%
132.0%
Beats: 5
Misses: 5
35.4%
144.6%
$13.8B
$2,877.4M
$26.45
19.7%
45.9%
Beat by 1.8%
Beat by 3.3%
(0.9%)
(3.0%)
Beats: 7
Misses: 3
9.1%
6.8%
$13.4B
$2,850.5M
$2.25
15.6%
490.9%
Beat by 6.2%
Beat by 22.4%
(0.9%)
7.4%
Beats: 8
Misses: 2
10.0%
48.9%
$13.3B
$0.0
($0.31)
(100.0%)
62.6%
undefinedN/A
undefinedN/A
0.0%
(8.4%)
Beats: 6
Misses: 4
N/A
11.4%

FAQ

1. When was Halozyme Therapeutics, Inc.'s last earnings date?

Halozyme Therapeutics, Inc.'s last earnings date was Dec'24 (Q4 2024).

2. What is Halozyme Therapeutics, Inc.'s EPS, and was there a surprise?

4. What is Halozyme Therapeutics, Inc.'s next quarter EPS estimate?

Halozyme Therapeutics, Inc.'s next quarter EPS estimate is $0.97, with an expected 22.8% YoY growth.